[{"from": "human", "value": "Please give me some details about this molecule. [C][N][C][=Branch1][#Branch1][=N][N][C][Ring1][Branch1][=O][C][N][C][=C][C][=Branch2][Ring1][Branch2][=C][Branch1][Branch1][C][Ring1][=Branch1][=O][O][C][=C][C][=Branch1][#Branch2][=C][C][=Branch1][Ring2][=C][Ring1][=Branch1][C][#N][Cl][C][Branch1][C][F][Branch1][C][F][F]"}, {"from": "gpt", "value": "The molecule is an HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI) intended to be administered in combination with other antiretroviral medicines. Doravirine is available by itself or as a combination product of doravirine (100 mg), lamivudine (300 mg), and tenofovir disoproxil fumarate (300 mg).  Doravirine is formally indicated for the treatment of HIV-1 infection in adult patients with no prior antiretroviral treatment experience, further expanding the possibility and choice of therapeutic treatments available for the management of HIV-1 infection."}]